Supervisor: Dr Guiping Wang
Department/Location: Cancer Research UK Cambridge Institute
Course start date: 5th Jan 2027
Deadline for application: 6th July 2026
Overview
Dr Guiping Wang will be joining the CRUK Cambridge Institute as a Group Leader later this year. Her laboratory focuses on the spatial genomics of cancer, with a particular interest in how extrachromosomal DNA (ecDNA) drives oncogene amplification and therapy resistance. By developing and applying advanced imaging and epigenomic sequencing technologies, the Wang Group aims to map gene regulation at multiple scales, from single molecules to genome-wide circuits, to uncover new targetable vulnerabilities in aggressive cancers. The Institute's strengths are in genomics, computational biology, and imaging, with a focus on breast, pancreas, brain and colon cancers. We are committed to providing an inclusive and supportive working environment that fosters intellectual curiosity and scientific excellence.
Project Details
In the Wang Group, we develop and apply interdisciplinary technologies that bridge high-resolution spatial biology and genome-wide discovery. By integrating multi-omic sequencing and quantitative imaging, we work towards a multi-scale understanding of how molecular composition and subcellular organisation shape cell function, plasticity and disease. A central biology focus of the lab is extrachromosomal DNA (ecDNA) circular DNA elements that drive oncogene amplification, intratumour heterogeneity and therapeutic resistance across many aggressive solid cancers. This PhD project will help develop and apply cutting‑edge single‑cell and spatial multi‑omic approaches that link molecular signatures to cancer cell vulnerabilities. Working at the interface of molecular, chemical and optical method development and cancer biology, the student will build tools that connect molecular mechanisms of gene regulation to cellular phenotypes in cancer cells, and use them to dissect how ecDNA is organised, regulated and exploited in cancer.
Preferred Skills/Knowledge
We are looking for a curious, motivated and collaborative student with a strong background in interdisciplinary science at the intersection of molecular biology, genomics, microscopy and computation. Applicants should hold (or expect to gain) an undergraduate or Master's degree in biophysics, biology, physics, chemistry, bioengineering, physical chemistry, biomedical sciences, or a related discipline.
Funding
This four‑year studentship is funded by Cancer Research UK Cambridge Institute and includes full funding for University fees and an index‑linked stipend starting at £22,500 for four years in 2026‑27.
Eligibility
We welcome applications from both UK and overseas students. Applications are invited from recent graduates or final‑year undergraduates who hold or expect to gain a First/Upper Second Class degree (or equivalent) in a relevant subject from any recognised university worldwide. Applicants with relevant research experience, gained through Master's study or while working in a laboratory, are strongly encouraged to apply.
How to Apply
Please apply via the University Applicant Portal. For further information about the course and to access the Applicant Portal, visit https://www.postgraduate.study.cam.ac.uk/courses/directory/cvcrpdmsc. You should select to commence study in Lent Term (January) 2027.
Deadline
The closing date for applications is Monday 6th July 2026, with in‑person interviews expected to take place in September 2026.
#J-18808-Ljbffr